Parul Doshi
12Patents
7h-index
11Co-inventors
59Inventor score
Filing activity: Aug 15, 2002 → Sep 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9603927B2 | Combination therapies with anti-CD38 antibodies | Chemistry; Metallurgy | 25 | Active |
| US9732154B2 | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia | Chemistry; Metallurgy | 19 | Active |
| US10556961B2 | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia | Chemistry; Metallurgy | 15 | Active |
| US10668149B2 | Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors | Chemistry; Metallurgy | 13 | Active |
| US10766965B2 | Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies | Chemistry; Metallurgy | 12 | Active |
| US10793630B2 | Anti-CD38 antibodies for treatment of acute myeloid leukemia | Chemistry; Metallurgy | 10 | Active |
| US10800851B2 | Combination therapies with anti-CD38 antibodies | Chemistry; Metallurgy | 10 | Active |
| US11713355B2 | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia | Chemistry; Metallurgy | 3 | Active |
| US12091466B2 | Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies | Chemistry; Metallurgy | 1 | Active |
| US12060432B2 | Combination therapies with anti-CD38 antibodies | Chemistry; Metallurgy | 1 | Active |
| US7320996B2 | Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer | Human Necessities | 0 | Expired |
| US12286474B2 | Anti-CD38 antibodies for treatment of acute myeloid leukemia | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.